NK/T-CELL LYMPHOMA
Clinical trials for NK/T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NK/T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for NK/T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to boost stem cell transplant success in rare lymphoma
Disease control Not yet recruitingThis study tests whether a combination of three chemotherapy drugs (thiotepa, cyclophosphamide, and busulfan) given before a stem cell transplant can help people with NK/T-cell lymphoma live longer without their cancer coming back. About 37 adults aged 18 to 70 who are in remissi…
Matched conditions: NK/T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated May 26, 2026 11:41 UTC
-
New drug combo targets Tough-to-Treat lymphoma
Disease control Not yet recruitingThis study tests a combination of two drugs, tislelizumab and zeprumetostat, in people with a rare type of lymphoma (NK/T-cell) that has returned or not responded to prior treatment. About 107 adults will take part to find the best dose and measure how well the drugs shrink tumor…
Matched conditions: NK/T-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Rong Tao • Aim: Disease control
Last updated May 26, 2026 11:38 UTC
-
Triple-Drug attack shows promise against rare, aggressive blood cancer
Disease control Not yet recruitingThis study tests a new combination of three drugs (golidocitinib, pegaspargase, and an immunotherapy) as the first treatment for people with advanced NK/T-cell lymphoma, a rare and aggressive blood cancer. The goal is to see if this combo can shrink tumors and improve survival be…
Matched conditions: NK/T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: LIANG WANG • Aim: Disease control
Last updated May 26, 2026 11:32 UTC
-
New drug combo aims to stop lymphoma relapse after transplant
Disease control Not yet recruitingThis study tests whether a combination of two drugs, selinexor and azacitidine, can help prevent NK/T-cell lymphoma from returning after a stem cell transplant. About 39 adults who have already had a transplant will receive this maintenance therapy. The goal is to see if the trea…
Matched conditions: NK/T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated May 26, 2026 11:28 UTC